Skip to Content Facebook Feature Image

Workato Named a Leader in the 2025 Gartner® Magic Quadrant™ for iPaaS

Business

Workato Named a Leader in the 2025 Gartner® Magic Quadrant™ for iPaaS
Business

Business

Workato Named a Leader in the 2025 Gartner® Magic Quadrant™ for iPaaS

2025-05-23 15:09 Last Updated At:15:35

Workato received 4.9/5 ratings in Gartner Peer Insightsâ„¢ as of 20th May 2025, based on 452 reviews

SYDNEY, May 23, 2025 /PRNewswire/ -- Workato®, the leading Enterprise Orchestration platform, announced today that it has again been recognized as a Leader with the furthest in vision placement in the 2025 Gartner® Magic Quadrantâ„¢ for Integration Platform as a Service. Workato has been named a Leader seven consecutive times for its ability to execute, and completeness of vision, with the furthest in vision placement for the second year.

Workato enables enterprises to transform their business operations by orchestrating business processes end-to-end and operationalizing AI across the entire organization. Designed with best-in-class security and governance, scalability, performance, and availability, Workato's low-code, no-code platform makes it seamless and fast for IT and business teams to orchestrate their applications, data, and experiences.

"Since starting Workato over 10 years ago, our main focus has been how we drive value for our customers — their success, future, and transformation. To be recognized as a Leader with the furthest in vision in this year's Magic Quadrant for iPaaS is an honor for us," said Vijay Tella, CEO and Co-founder of Workato. "We believe Workato is being recognized for its capabilities in driving transformative results and our commitment to customer success, collaboration, and transformation through AI."

In addition to being named a Leader in the report, Workato has an overall rating, 4.9 out of 5, the highest number of reviews on Gartner Peer InsightsTM, as of May 19, 2025. Customers who have shared their experience of using Workato in the past year include:

"Our industry is witnessing the remarkable evolution of iPaaS, especially with the infusion of AI orchestration. The future of iPaaS goes beyond traditional integrations, transforming into enterprise orchestration platforms that enable intelligent and composable business processes," said Markus Zirn, Chief Strategy Officer at Workato. "It is through the trust and collaboration of our customers that we continue to advance and shape the future of automation and integration. We are excited to continue this journey together, exploring new frontiers and unlocking new possibilities for business transformation. We believe being named a Leader by Gartner with the furthest in completion of vision is a testament to our team's dedication to transforming the industry."

A Gartner Magic Quadrant provides a graphical competitive positioning of four types of technology providers in markets where growth is high and provider differentiation is distinct.

This recognition follows a year of milestones and acceleration for the company including recently announced strategic alliances with Amazon Bedrock and Anthropic, and the launch of Workato One, the industry's only platform that brings together everything organizations need to build and deploy secure, trusted, enterprise-ready agents with full business context across the core of the enterprise. Along with being named to this year's Deloitte Technology Fast 500 and Forbes Cloud 100 rankings, Workato also experienced a year of growth from a leadership standpoint, appointing the company's first Chief Go-to-Market Officer, Chief of AI Products & Solutions, and a new head of Product & Engineering.

Access a complimentary copy of the report and learn more about Workato here.

Gartner, Magic Quadrant for Integration Platform as a Service, Andrew Humphreys, Andrew Comes, Keith Guttridge, and Allan Wilkins.,19 May 2025.

Gartner does not endorse any vendor, product, or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designations. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Gartner, Voice of the Customer for Integration Platform as a Service, 31 July 2024, By Peer Contributors

Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, MAGIC QUADRANT and PEER INSIGHTS are registered trademarks of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

About Workato

Workato transforms technology complexity into business opportunity. As the leading Agentic Orchestration company, Workato empowers enterprises to connect and unify data, processes, applications, and experiences. Its AI-driven platform enables teams to navigate complex workflows in real-time, driving efficiency and agility. Trusted by more than 12,000 global customers, Workato empowers organizations of every size to unlock new value and lead in today's fast-changing world. Learn how Workato helps businesses of all sizes achieve more at workato.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Workato Named a Leader in the 2025 Gartner® Magic Quadrant™ for iPaaS

Workato Named a Leader in the 2025 Gartner® Magic Quadrant™ for iPaaS

  • Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
  • Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
  • Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users.

MILFORD, Mass., Sept. 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.

The new cell analyzer expands Waters' category-defining FACSDiscover platform of flow cytometers, incorporating the same cutting-edge BD SpectralFX Technology present in the flagship BD FACSDiscover A8 Cell Analyzer, which supports up to five lasers and 78 fluorescence detectors to maximize the palette of colors. This technology enables scientists to analyze more than 50 characteristics of a single cell with consistent, high-quality data.

Together with FACSTruQ Technology, a notable product innovation that delivers next-generation instrument calibration with automated setup and quality control, the cell analyzer provides data consistency across instruments, users, and sites, achieving highly reproducible results with a less than 10% coefficient of variation across a palette of more than 50 dyes.1 Paired with the BD FACSChorus Software's guided workflows and the integrated autoloader, the FACSDiscover A7 Cell Analyzer sets a new standard for experimental standardization in flow cytometry.

"The FACSDiscover A7 Cell Analyzer lowers the barrier to advanced spectral flow cytometry and will open up new possibilities for immunology research, enabling our core facility to help scientists uncover deeper biological insights with greater standardization and confidence," said Cheryl Kim, Senior Director, Flow Cytometry Core, La Jolla Institute for Immunology. "We look forward to the FACSDiscover A7 Cell Analyzer being an integral instrument for our core, allowing our researchers to get the most out of spectral data to advance our important work of improving human health through the development of treatments and cures for immune system disorders."

Steve Conly, Senior Vice President, Waters Biosciences, Waters Corporation, added, "The FACSDiscover A7 Cell Analyzer couples advanced spectral performance and leading standardization with a compelling price-to-performance balance, bringing spectral flow cytometry within reach of more researchers than ever before, for applications from biomarker discovery to drug development. Just two years after the world's very first 50-color flow cytometry panel was developed on the BD FACSDiscover™ S8 Cell Sorter,2 the FACSDiscover A7 Cell Analyzer extends these transformative capabilities, helping labs meet their increasingly critical needs for reproducibility within our connected ecosystem of instruments, reagents, and informatics."

The FACSDiscover A7 Cell Analyzer is now commercially available globally and available to order through local representatives. For more information, please visit waters.com and bdbiosciences.com/A7.

BD is a trademark of Becton, Dickinson and Company. Waters is a trademark of Waters Corporation or its affiliates.  All other marks are the property of their respective owners.

About Waters Corporation:

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~15,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Disclaimer:

The BD Biosciences and BD Diagnostic Solutions businesses have been acquired by Waters Corporation ("Waters"). Becton, Dickinson and Company or one of its affiliates or subsidiaries ("BD") remains the legal manufacturer of Biosciences and Diagnostic Solutions products until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under BD's regulatory authority. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary: www.waters.com/bdtransaction.

References:

1) Internal Waters data comparing the BD FACSDiscover™ A7 Cell Analyzer with the BD FACSLyric™ Flow Cytometry System and publicly available data for comparable instruments.

2) Konecny AJ, Mage PL, Tyznik AJ, Prlic M and Mair F. OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. Cytometry Part A 2024; 105:430-436. DOI: 10.1002/cyto.a.24841 

Contact:

Molly Gluck
Head of External Communications
Waters Corporation
+1.508.498.9732
molly_gluck@waters.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Recommended Articles